Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy.
Xie Y, Zhou T, Li X, Zhao K, Bai W, Hou X, Liu Z, Ni B, Zhang Z, Yan J, Wang Y, Jiang W, Wang H, Chang A, Gao S, Zhao T, Yang S, Huang C, Liu J, Hao J.
Xie Y, et al. Among authors: ni b.
Gastroenterology. 2024 Jul;167(2):281-297. doi: 10.1053/j.gastro.2024.02.046. Epub 2024 Mar 15.
Gastroenterology. 2024.
PMID: 38492894